Showing 1481-1490 of 8821 results for "".
Know Your Lesions: The Many Variations of Seborrheic Keratosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/know-your-lesions-the-many-variations-of-seborrheic-keratosis/20679/SKs are benign lesions that may be removed for medical or aesthetic reasons. It's essential to distinguish SKs from malignant lesions.Meet the New Crop of Pigment Correctors
https://practicaldermatology.com/topics/pigmentary-disorders/meet-the-new-crop-of-pigment-correctors/23767/Hydroquinone is no longer the only game in town. In fact, alternatives are now more readily available and show good efficacy.On Dosage and Diet: Isotretinoin 101
https://practicaldermatology.com/topics/general-topics/on-dosage-and-diet-isotretinoin-101/21445/Isotretinoin is one of the most essential agents in the treatment of acne, but dietary and dosage considerations must be made to maximize efficacy. Author:Joshua Zeichner, MDOptimizing Isotretinoin Treatment: Keys to Successful Prescribing and Management
https://practicaldermatology.com/topics/practice-management/optimizing-isotretinoin-treatment-keys-to-successful-prescribing-and-management/21193/Embraced by the dermatology community, isotretinoin is still considered controversial by some patients. Here are tips on navigating the prescribing process to improve patient comfort and adherence.Case Study: Recurrent Generalized Pustular Psoriasis
https://practicaldermatology.com/issues/august-2025/recurrent-generalized-pustular-psoriasis/36711/This article reports the case of a 74-year-old white man with a history of psoriatic arthritis and congestive heart failure who presented with two separate episodes of GPP. Both of these episodes were associated with hypocalcemia and required inpatient hospitalization.The State of Private Equity in 2024: Impact on the Practice of Dermatology
https://practicaldermatology.com/columns/practice-management/state-private-equity-2024-impact-practice-dermatology/27173/Physician Growth Partners recently published a white paper, “State of Dermatology Private Equity,” that evaluated market trends, strategies, and more. Practical Dermatology® spoke exclusively with CEO Michael Kroin about how the evolution of private equity is impacting the everyday practitioner andHow Physicians Are Unlike Most US Investors
https://practicaldermatology.com/topics/practice-management/how-physicians-are-unlike-most-us-investors/23370/A look at how the difference in the tax situations of physicians and average retail investors, and why these differences matter.OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?The Challenges of Topical Steroid Withdrawal
https://practicaldermatology.com/topics/practice-management/the-challenges-of-topical-steroid-withdrawalogy/21118/Now more widely reported, topical steroid addiction should compel all prescribers to reflect on their use of topical corticosteroids.Turmeric, Curcumin, and Curcuminoids: A Dermatologic Review
https://practicaldermatology.com/columns/clinical-focus-1/turmeric-curcumin-and-curcuminoids-a-dermatologic-review/23377/Curcumin, one of the active compounds of turmeric, exhibits anti-inflammatory, antimicrobial, antioxidant, anti-nociceptive, and antineoplastic properties.